Search Results - Hekmati, Ava

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb

    Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb by Chen, Haiming, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Deighton, Charles David, Xu, Ning, Berenson, James R.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity

    Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity by Chen, Haiming, Souther, Eric, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Xu, Ning, Berenson, James R.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo

    Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo by Chen, Haiming, Souther, Eric, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Xu, Ning, Berenson, James R.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients

    The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients by Xu, Ning, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Deighton, Charles David, Chen, Haiming, Berenson, James R.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Anti-Myeloma Effects of Panobinostat in Combination with Duvelisib

    Anti-Myeloma Effects of Panobinostat in Combination with Duvelisib by Chen, Haiming, Li, Mingjie, Goldwater, Marissa, Behare, Stacy, Cao, Jasmin, Wallingford, Cara, Hekmati, Ava, Levin, Rocky, Souther, Eric, Xu, Ning, Berenson, James R.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma

    The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma by Xu, Ning, Yu, Erin, Ng, Nicole, Li, Mingjie, Bujarski, Sean, Hekmati, Ava, Nassir, Isabella, Hekmati, Tara, Yu, Janna, Daniely, David, Wang, Cathy S., Kim, Clara, Chen, Haiming, Berenson, James R.

    Published in Hematological oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 4195: Evaluation of the anti-myeloma effects of high and metronomic selinexor alone and in combination with duvelisib in vitro and in vivo

    Abstract 4195: Evaluation of the anti-myeloma effects of high and metronomic selinexor alone and in combination with duvelisib in vitro and in vivo by Chen, Haiming, Behare, Stacy, Li, Mingjie, Goldwater, Marissa, Hekmati, Ava, Cao, Jasmin, Levin, Rocky, Xu, Ning, Berenson, James

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: